Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances.

E, M., W, A., P, K., & A, S. (2026). Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances.. Cardiovascular therapeutics. https://doi.org/10.1155/cdr/5159097

E M, W A, P K, A S. Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances.. Cardiovascular therapeutics. 2026; doi: 10.1155/cdr/5159097

E M, W A, P K, et al. Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances.[J]. Cardiovascular therapeutics. 2026. DOI: 10.1155/cdr/5159097.

@article{e2026,
  author = {Mirhadi E and Almahmeed W and Kesharwani P and Sahebkar A},
  title = {Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances.},
  journal = {Cardiovascular therapeutics},
  year = {2026},
  doi = {10.1155/cdr/5159097},
  note = {PMID: 42608966},
}

TY  - JOUR
AU  - Mirhadi E
AU  - Almahmeed W
AU  - Kesharwani P
AU  - Sahebkar A
TI  - Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances.
T2  - Cardiovascular therapeutics
PY  - 2026
DO  - 10.1155/cdr/5159097
AN  - PMID:42608966
ER  -